Sign in to continue:

Sunday, April 5th, 2026

Category: Singapore SGX stocks

Singapore SGX stocks

Hyphens Pharma Q3 Results: Revenue Growth Slows, Maintains “Add” Rating

Comprehensive Analysis of Hyphens Pharma and Market Peers ...

StarHub Q3 2024 Earnings: Strong Growth Ahead as Dare+ Transformation Nears Completion

Comprehensive Analysis of Telco Companies Comprehensive A...

UOB Stock Analysis: Strong Uptrend and Bullish Signals Point to Potential Gains

Singapore Retail Research: Comprehensive Analysis of Listed ...

From TA and FA perspective, this company has 39% upside.

The company 1H24 Financial Performance: Revenue and Profi...